Adipose Tissue Gene Expression and Metabolomics Links to the Gut Microbiome-brain Axis (POINSETTIA Study)

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This study aims to understand how adipose tissue (fat) and the gut microbiota (the bacteria in the gut) may influence brain function and cognition. It has been observed that changes in adipose tissue in animals such as mice and Drosophila (a type of insect) affect memory and other brain functions. Additionally, it is believed that the gut microbiota also plays an important role in cognition. This study will explore how gene expression in adipose tissue, blood metabolites, and the gut microbiota are related to cognitive function, such as memory and thinking, in individuals with and without obesity. The investigation will also assess whether these factors can predict changes in the brain over time and how they influence sleep, physical activity, and blood sugar regulation. Advanced technologies will be used to analyze samples of tissue, blood, and microbiota, with the goal of identifying new mechanisms through which obesity affects the brain. This research may contribute to the development of new diagnostic and therapeutic strategies for cognitive problems in individuals with obesity.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Healthy Volunteers: f
View:

• Men and women \>20 years old.

• Scheduled for surgical intervention to extract adipose tissue.

• Signed informed consent for study participation.

Locations
Other Locations
Spain
Institut d'Investigació Biomèdica de Girona (IDIBGI)
RECRUITING
Girona
Contact Information
Primary
José Manuel Fernández-Real, M.D., Ph.D.
jmfreal@idibgi.org
+34972940200
Time Frame
Start Date: 2025-05
Estimated Completion Date: 2028-04
Participants
Target number of participants: 100
Treatments
OBESITY
With 2 subgroups~* Man with obesity~* Women with obesity
WITHOUT OBESITY
With 2 subgroups:~* Man without obesity~* Women without obesity
Related Therapeutic Areas
Sponsors
Leads: Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta

This content was sourced from clinicaltrials.gov